OnPoint NYC

Last updated
OnPoint NYC
Formation2021
Merger ofNew York Harm Reduction Educators, Washington Heights Corner Project
Type Nonprofit
Purpose safe injection sites and other harm reduction services
Location
  • New York City
LeaderSam Rivera
Staff~120 [1] (2023)
Website onpointnyc.org

OnPoint NYC is a New York City nonprofit that operates two privately run safe injection sites (also known as Overdose Prevention Centers) in East Harlem and Washington Heights. [2] Placed at the sites of existing syringe service programs, [3] these were America's first safe injection facilities when they opened in November 2021. [2]

Contents

History

OnPoint was created in 2021 from the merger of two existing groups, New York Harm Reduction Educators and Washington Heights Corner Project. [3] [4] OnPoint's workers voted to unionize with UNITE HERE in December 2022. [1] In their first year of operation, OnPoint's sites served over 2,100 clients and treated 672 overdoses, with no resulting deaths. [5]

New York mayor Bill de Blasio had been advocating for the city to open safe injection sites since 2018. [3] The opening of OnPoint's OPCs is one demonstration of a shift toward harm reduction in American drug policy, prompted by a worsening opioid overdose crisis and an illicit drug supply containing high levels of fentanyl. [4] [6] Under President Joe Biden, the United States Department of Justice has taken a hands-off approach to safe injection sites, [7] although possession of opioids without a prescription remains illegal. On August 7, 2023, the top federal prosecutor for Manhattan announced OnPoint's activities are illegal, because it is a violation of federal law to maintain property where controlled substances are consumed. [8]

Some Harlem activists and politicians (including Al Taylor, Inez Dickens, Yusef Salaam, Rev. Al Sharpton and Adriano Espaillat) have criticized the Harlem site, viewing it as part of an oversaturation of shelters and addiction treatment facilities in the neighborhood. [9] [10] [11] A December 2021 protest in Harlem against the site drew over 100 people. [9] Gothamist and WNYC reviewed 2019–2020 data of opioid clinic usage in Harlem and found that only 25% of patients were Harlem residents. [12]

Some Harlem residents have also complained of increased crime (including drug dealing and public drug use) in the area since the site opened. [13] The New York Times reported visible drug activities around the block at OnPoint's E 126th St location in August, 2023. [8] The consumption site is across the street from a child care center. [14] OnPoint also employs staff to collect discarded drug paraphernalia in parks and other public areas. [2]

Funding

OnPoint has received funding from the New York City Department of Health and Mental Hygiene, [15] The New York Community Trust [10] and the New York Health Foundation, [10] among other sources. As of June 2022 it had received no state or federal funding. [16] Counseling, syringe service programs and other services offered around the consumption sites receive city and state funding, but the consumption sites are privately funded. [9]

Research

In 2023 NYU Langone Health and Brown University announced that OnPoint would be included in the first federally-funded study to evaluate the effectiveness of OPCs. [17] [6] This study will be funded by NIDA. [6]

See also

Related Research Articles

<span class="mw-page-title-main">Harm reduction</span> Public health policies which lessen negative aspects of problematic activities

Harm reduction, or harm minimization, refers to a range of intentional practices and public health policies designed to lessen the negative social and/or physical consequences associated with various human behaviors, both legal and illegal. Harm reduction is used to decrease negative consequences of recreational drug use and sexual activity without requiring abstinence, recognizing that those unable or unwilling to stop can still make positive change to protect themselves and others.

<span class="mw-page-title-main">Naloxone</span> Opioid receptor antagonist

Naloxone, sold under the brand name Narcan among others, is an opioid antagonist, a medication used to reverse or reduce the effects of opioids. For example, it is used to restore breathing after an opioid overdose. Effects begin within two minutes when given intravenously, five minutes when injected into a muscle, and ten minutes as a nasal spray. Naloxone blocks the effects of opioids for 30 to 90 minutes.

<span class="mw-page-title-main">Drug overdose</span> Use of an excessive amount of a drug

A drug overdose is the ingestion or application of a drug or other substance in quantities much greater than are recommended. Typically the term is applied for cases when a risk to health is a potential result. An overdose may result in a toxic state or death.

<span class="mw-page-title-main">Needle and syringe programmes</span> Method of providing drug users with uninfected equipment

A needle and syringe programme (NSP), also known as needle exchange program (NEP), is a social service that allows injection drug users (IDUs) to obtain clean and unused hypodermic needles and associated paraphernalia at little or no cost. It is based on the philosophy of harm reduction that attempts to reduce the risk factors for blood-borne diseases such as HIV/AIDS and hepatitis.

<span class="mw-page-title-main">Supervised injection site</span> Medical facility

Supervised injection sites (SIS) or drug consumption rooms (DCRs) are a health and social response to drug-related problems. They are fixed or mobile spaces where people who use drugs are provided with sterile drug use equipment and can use illicit drugs under the supervision of trained staff. They are usually located in areas where there is an open drug scene and where injecting in public places is common. The primary target group for DCR services are people who engage in risky drug use.

Needle sharing is the practice of intravenous drug-users by which a needle or syringe is shared by multiple individuals to administer intravenous drugs such as heroin, steroids, and hormones. This is a primary vector for blood-borne diseases which can be transmitted through blood. People who inject drugs (PWID) are at an increased risk for Hepatitis C (HCV) and HIV due to needle sharing practices. From 1933 to 1943, malaria was spread between users in the New York City area by this method. Afterwards, the use of quinine as a cutting agent in drug mixes became more common. Harm reduction efforts including safe disposal of needles, supervised injection sites, and public education may help bring awareness on safer needle sharing practices.

<span class="mw-page-title-main">Insite</span> Safe drug injection facility in Vancouver, B.C., Canada

Insite is a supervised drug injection site in the Downtown Eastside (DTES) neighbourhood of Vancouver, British Columbia, Canada The DTES had 4,700 chronic drug users in 2000 and has been considered to be the centre of an "injection drug epidemic". The site provides a supervised and health-focused location for injection drug use, primarily heroin. The clinic does not supply any drugs. Medical staff are present to provide addiction treatment, mental health assistance, and first aid in the event of an overdose or wound. In 2017, the site recorded 175,464 visits by 7,301 unique users; 2,151 overdoses occurred with no fatalities, due to intervention by medical staff. The site also offers a free checking service so clients can check their substances for fentanyl and carfentanil. Health Canada has provided $500,000 per year to operate the site, and the BC Ministry of Health contributed $1,200,000 to renovate the site and cover operating costs. Insite also serves as a resource for those seeking to use a harm reduction approach for people who inject drugs around the world. In recent months and years, delegations from a number of countries are on record touring the facility, including various U.S. states, Colombia and Brazil. 95% of drug users who use Insite also inject on the street according to a British Columbia health official.

<span class="mw-page-title-main">Opioid overdose</span> Toxicity due to excessive consumption of opioids

An opioid overdose is toxicity due to excessive consumption of opioids, such as morphine, codeine, heroin, fentanyl, tramadol, and methadone. This preventable pathology can be fatal if it leads to respiratory depression, a lethal condition that can cause hypoxia from slow and shallow breathing. Other symptoms include small pupils and unconsciousness; however, its onset can depend on the method of ingestion, the dosage and individual risk factors. Although there were over 110,000 deaths in 2017 due to opioids, individuals who survived also faced adverse complications, including permanent brain damage.

<span class="mw-page-title-main">Vancouver Area Network of Drug Users</span> Organization

The Vancouver Area Network of Drug Users or VANDU is a not-for-profit organization and advocacy group based in Vancouver, British Columbia, Canada. The group believes that all drug users should have their own rights and freedoms. The group's members have been actively involved in lobbying for support of Insite, North America's first safe injection site, located in the Downtown Eastside of Vancouver.

<span class="mw-page-title-main">Boston Public Health Commission</span>

The Boston Public Health Commission, the oldest health department in the United States, is an independent public agency providing a wide range of health services and programs. It is governed by a seven-member board of health appointed by the Mayor of Boston. Its mission is to "protect, preserve, and promote the health and well-being of all Boston residents, particularly those who are most vulnerable." The commission is headquartered at 1010 Massachusetts Avenue in Boston.

Responsible drug use seeks to maximize the benefits and minimize the risks associated with psychoactive drug use. For illegal psychoactive drugs that are not diverted prescription controlled substances, some critics believe that illegal recreational drug use is inherently irresponsible, due to the unpredictable and unmonitored strength and purity of the drugs and the risks of addiction, infection, and other side effects.

<span class="mw-page-title-main">Opioid epidemic in the United States</span> Ongoing overuse of opioid medication in the US

There is an ongoing opioid epidemic in the United States, originating out of both medical prescriptions and illegal sources. It has been called "one of the most devastating public health catastrophes of our time". The opioid epidemic unfolded in three waves. The first wave of the epidemic in the United States began in the late 1990s, according to the Centers for Disease Control and Prevention (CDC), when opioids were increasingly prescribed for pain management, resulting in a rise in overall opioid use throughout subsequent years. The second wave was from an expansion in the heroin market to supply already addicted people. The third wave, starting in 2013, was marked by a steep tenfold increase in the synthetic opioid-involved death rate as synthetic opioids flooded the US market.

A take-home naloxone program is a governmental program that provides naloxone drug kits to those that are at risk of an opioid overdose. Naloxone is a medication that was created to reverse opioid overdoses. As an opioid antagonist, it binds to the μ-opioid receptors blocking the opioid's effects. Naloxone quickly restores normal respiration. The ongoing opioid epidemic has caused many public health authorities to expand access to naloxone.

<span class="mw-page-title-main">Opioid epidemic</span> Deaths due to abuse of opioid drugs

The opioid epidemic, also referred to as the opioid crisis, is the rapid increase in the overuse, misuse/abuse, and overdose deaths attributed either in part or in whole to the class of drugs called opiates/opioids since the 1990s. It includes the significant medical, social, psychological, demographic and economic consequences of the medical, non-medical, and recreational abuse of these medications.

<span class="mw-page-title-main">ARCHES Lethbridge</span> Non-profit organization

ARCHES is a non-profit organization based in Lethbridge, Alberta, that works to reduce the harm associated with HIV/AIDS and Hepatitis C, known for operating the province-funded Lethbridge Supervised Consumption Site from February 2018 until closing in August 2020. ARCHES started in 1986, specifically focused on helping the gay community. Over time, ARCHES became a community-based organization. The SCS it operated was the busiest drug consumption site in North America. It decided to close the site following the withdrawal of government funding after an initial audit found evidence of various misappropriation of funds and lack of accounting for more than a million dollars of its funding. The concerns around unaccounted funds were investigated by Lethbridge Police Service Economics Crimes Unit, which located the missing financial records, resulting in no criminal charges. While criminally not charged, funding to the organization remains withheld as some of their spending did not comply with grant agreement.

Harm reduction consists of a series of strategies aimed at reducing the negative impacts of drug use on users. It has been described as an alternative to the U.S.'s moral model and disease model of drug use and addiction. While the moral model treats drug use as a morally wrong action and the disease model treats it as a biological or genetic disease needing medical intervention, harm reduction takes a public health approach with a basis in pragmatism. Harm reduction provides an alternative to complete abstinence as a method for preventing and mitigating the negative consequences of drug use and addiction.

<span class="mw-page-title-main">Project Weber/RENEW</span> Harm reduction organization in Rhode Island, United States

Project Weber/RENEW is a harm reduction organization in Providence, Rhode Island established in 2016 by the merger of Project RENEW and Project Weber. The organization is staffed entirely by people who have directly experienced mental health issues, substance abuse and/or sex work.

Aubri Esters was an American activist for the rights of drug users.

<span class="mw-page-title-main">Response to the Opioid Crisis in New Jersey</span> Policy

New Jersey's most recent revised policy was issued September 7, 2022 pursuant to P.L.2021, c.152 which authorized opioid antidotes to be dispensed without a prescription or fee. Its goal is to make opioid antidotes widely available, reducing mortality from overdose while decreasing morbidity in conjunction with sterile needle access, fentanyl test strips, and substance use treatment programs. A $67 million grant provided by the Department of Health and Human Services provides funding for naloxone as well as recovery services. This policy enables any person to distribute an opioid antidote to someone they deem at risk of an opioid overdose, alongside information regarding: opioid overdose prevention and recognition, the administration of naloxone, circumstances that warrant calling 911 for assistance with an opioid overdose, and contraindications of naloxone. Instructions on how to perform resuscitation and the appropriate care of an overdose victim after the administration of an opioid antidote should also be included. Community first aid squads, professional organizations, police departments, and emergency departments are required to "leave-behind" naloxone and information with every person who overdosed or is at risk of overdosing.

<span class="mw-page-title-main">National Harm Reduction Coalition</span> American harm reduction advocacy group

The National Harm Reduction Coalition, previously known as the Harm Reduction Coalition, is an American advocacy organization for people who use drugs.

References

  1. 1 2 Murray, Nick. "OnPoint NYC, a Trailblazing Harm-Reduction Organization, May Soon Be a Union Shop". Jacobin.
  2. 1 2 3 Kim, Phenix (2022-12-03). "New York City's first safe injection sites avert 633 drug overdoses on anniversary". NYN Media. Retrieved 2023-06-15.
  3. 1 2 3 Mays, Jeffery C.; Newman, Andy (2021-11-30). "Nation's First Supervised Drug-Injection Sites Open in New York". The New York Times. ISSN   0362-4331 . Retrieved 2023-06-15.
  4. 1 2 Oladipo, Gloria (January 25, 2022). "'It's saved many lives': first US overdose prevention centers give safe spaces to people in crisis". The Guardian.
  5. Whelan, Aubrey. "New York's supervised injection sites have halted nearly 700 overdoses in just over a year". Philadelphia Inquirer.
  6. 1 2 3 Johnson, Steven Ross. "Safe Consumption Sites Study Aims to 'Rise Above the Politics'". U.S. News & World Report. Retrieved 2023-05-16.
  7. "Justice Dept. signals it may allow safe injection sites". AP NEWS. February 7, 2022.
  8. 1 2 Otterman, Sharon (2023-08-08). "Federal Officials May Shut Down Overdose Prevention Centers in Manhattan". The New York Times. Retrieved 2023-08-11.
  9. 1 2 3 "A look inside the 1st official 'safe injection sites' in US". Associated Press . 2022-03-09. Retrieved 2023-08-12.
  10. 1 2 3 Wernau, Julie (March 2, 2023). "New York City Sanctioned Drug-Use Sites Reach a Crossroads". WSJ.
  11. Guilfoil, Kyla (June 9, 2023). "Harlem City Council candidates all oppose proliferation of drug-related services". POLITICO.
  12. O'Donnell, James (Dec 16, 2021). "Harlem Residents Protest Against Opioid Clinics After Data Shows Most Are Used By Non-Residents". Gothamist . Retrieved 2023-08-12.
  13. Johnson, Stephon (December 13, 2022). "Saving Lives or Ruining the Neighborhood? East Harlem Locals at Odds as America's First Safe Injection Site Turns One". The City.
  14. "Harlem City Council candidates all oppose proliferation of drug-related services". POLITICO. 2023-06-09. Retrieved 2023-08-12.
  15. Harocopos, Alex; Gibson, Brent E.; Saha, Nilova; McRae, Michael T.; See, Kailin; Rivera, Sam; Chokshi, Dave A. (July 15, 2022). "First 2 Months of Operation at First Publicly Recognized Overdose Prevention Centers in US". JAMA Network Open. 5 (7): e2222149. doi:10.1001/jamanetworkopen.2022.22149. PMC   9287749 . PMID   35838672 via Silverchair.
  16. https://www.npr.org/2022/06/04/1103114131/supervised-injection-sites-in-nyc-have-saved-lives-but-officials-wont-provide-fu
  17. Kaufman, Maya (2023-05-08). "NYU Langone, Brown launch NIH-funded study of overdose prevention centers". POLITICO. Retrieved 2023-06-15.